We confirmed these initial findings by RT-qPCR analysis, which showed that MAP3K19 mRNA expression is 2.5–7 fold greater in the lungs of COPD patients (Fig 1A). This evidence concerns the gene MAP3K19 and chronic obstructive pulmonary disease.